Immune Therapeutics, Inc.
IMUN · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $150 | $494 | $10 | $5 |
| Short-Term Investments | $0 | $2,645 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $150 | $3,139 | $10 | $5 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $763 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $51 | $0 | $0 | $0 |
| Total NC Assets | $813 | $0 | $0 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $964 | $3,139 | $10 | $6 |
| Liabilities | – | – | – | – |
| Payables | $1,300 | $2,185 | $2,563 | $2,656 |
| Short-Term Debt | $696 | $3,070 | $2,845 | $5,545 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $5,116 | $5,015 | $4,695 |
| Other Curr. Liab. | $1,480 | $716 | $1,254 | $798 |
| Total Curr. Liab. | $3,477 | $11,087 | $11,677 | $13,694 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1,997 | $0 | $0 | $0 |
| Other Liabilities | -$1,997 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,477 | $11,087 | $11,677 | $13,694 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $8 | $0 | $0 | $0 |
| Retained Earnings | -$382,968 | -$379,432 | -$383,018 | -$384,607 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $380,447 | $371,484 | $371,351 | $370,918 |
| Total Equity | -$2,513 | -$7,948 | -$11,667 | -$13,689 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $964 | $3,139 | $10 | $6 |
| Net Debt | $546 | $2,576 | $2,835 | $5,540 |